BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report)’s stock price traded up 0.6% during trading on Thursday . The company traded as high as $13.50 and last traded at $13.27. 40,150 shares changed hands during trading, a decline of 41% from the average session volume of 68,449 shares. The stock had previously closed at $13.19.
BioStem Technologies Stock Performance
The stock has a market cap of $220.92 million, a price-to-earnings ratio of 19.51 and a beta of -0.53. The firm’s 50-day simple moving average is $14.82 and its two-hundred day simple moving average is $13.85.
About BioStem Technologies
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Articles
- Five stocks we like better than BioStem Technologies
- What Makes a Stock a Good Dividend Stock?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to Calculate Options Profits
- 5 Best Gold ETFs for March to Curb Recession Fears
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
